Heart Rate Variability After Sprint Interval Training in Cyclists and Implications for Assessing Physical Fatigue
Question
Can heart-rate variability measured before repeated sprint sets identify the onset of physical fatigue during a sprint interval exercise test in trained cyclists?
Summary
Well-trained mountain-bike cyclists completed an acute laboratory sprint interval exercise test: four sets of four 30-second maximal cycling sprints with long recoveries between sets. Heart-rate variability fell as more sprint sets accumulated, but it did not track average or peak power fatigue well, so HRV was not a good acute fatigue marker for this protocol.
Methodology
- 27 well-trained mountain-bike cyclists.
- 27 participants.
- Cycle ergometer.
- Work intervals: 30 s maximal sprint.
- Recovery: 90 s low-intensity cycling; 25-40 min between sets.
- Intensity: Maximal sprinting at 0.8 Nm/kg fixed torque.
- Several hours including long recoveries.
- Single acute test.
- Single day.
- Acute repeated-measures laboratory study
- Heart-rate variability, Power output, and Metabolic markers were tracked.
Outcomes
HRV
HRV indexes declined as repeated sprint sets accumulated.
RRNN, SDNN, and VLF decreased in set 2; all time/frequency indexes decreased in sets 3 and 4 versus set 1.
Power
Peak power fell earlier than average power.
Ppeak decreased in sets 2-4; Pavg decreased only in set 4.
HRV-fatigue link
HRV did not correlate with power-output fatigue.
No significant correlations between HRV changes and Pavg or Ppeak changes.
Metabolic markers
Oxygen uptake increased and hydrogen concentration decreased by set 4; lactate did not significantly change.
VO2tou increased in set 4; H+ decreased in set 4; La- p=0.176.
Insights
- HRV can reflect accumulated autonomic stress but not necessarily acute sprint fatigue.
- Power-output tracking is more relevant than HRV for deciding whether maximal sprint quality is falling.
- This protocol is athlete/lab-specific and not a general consumer HIIT template.
Limitations
- Acute-only study.
- No control group.
- Well-trained cyclist sample.
- Outliers removed before correlation analysis.
- Safety reporting not detailed.
Safety
- Adverse events and injuries were not reported.
- Between-set recovery was extended until blood pH returned to at least 7.35.